Abstract
Purpose
This study aimed to investigate whether the extended culture of day 3 (D3) embryos with low blastomere number to blastocyst following frozen–thawed embryo transfer improved the clinical outcomes.
Methods
This was a retrospective study of clinical data of women undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles in the Tangdu Hospital. The patients were divided into groups with 4–5, 6, 7–9 and > 9 cells based on the blastomere number of D3 embryos. The clinical outcomes were compared.
Results
In fresh transfer cycles, the implantation and clinical pregnancy rates significantly decreased, while the abortion rate significantly increased in the groups with 4–5 and 6 cells compared with those with 7–9 and > 9 cells. In frozen–thawed transfer cycles, the clinical pregnancy and implantation rates for a single blastocyst transfer cycle showed no significant differences in the groups with 4–5 and 6 cells compared with those with 7–9 and > 9 cells. However, the abortion rate was significantly higher in the group with 4–5 cells than in that with 7–9 and > 9 cells. In the double blastocyst transfer cycle, the clinical pregnancy rate showed no significant differences among the groups with 4–5, 6, and 7–9 cells.
Conclusion
The implantation and clinical pregnancy rates of D3 embryos with 6 cells significantly decreased; these embryos were not considered as high-quality embryos. Extended culture of D3 embryos with ≤ 6 blastomeres to blastocysts, particularly 6-cell embryos, resulted in a similar clinical pregnancy rate as that of blastocysts derived from D3 embryos with ≥ 7 blastomeres.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Embryos obtained from assisted reproductive technology (ART) are transferred into a woman’s uterus on day 3 after egg collection (D3). For achieving satisfactory pregnancy outcomes, embryos are usually graded according to the standardized scoring criteria for transfer. Currently, the criteria for evaluating embryo quality mainly depend on the number of blastomeres, degree of fragmentation, evenness of blastomeres, and other morphological indicators [1]. The number of blastomeres on D3 represents the cleavage rate of embryos and is regarded as the most critical indicator for predicting the developmental potential of embryos and pregnancy outcomes [1,2,3].
Studies have shown that D3 embryos with low blastomere number have significantly reduced developmental potential, negatively influencing the pregnancy rates [1,2,3]. Zhang et al. reported that D3 embryos with six, seven, and eight cells were good-quality embryos. They also demonstrated that D3 embryos with less than six blastomeres were associated with low clinical pregnancy rate and increased abortion rate [4]. Alikani et al. found that the embryos with seven to nine blastomeres had higher developmental potential and blastocyst formation rate compared with embryos having less than seven blastomeres or more than nine blastomeres [5]. Kong et al. also indicated that ≥ 7 blastomeres in the embryos showed higher developmental potential, which decreased for ≤ 6 blastomeres in the embryos [2]. These results indicated that the transfer of D3 embryos with lower mean number of blastomeres significantly resulted in reduced implantation and clinical pregnancy rates and increased abortion rate [2, 6]. However, different classifications were forwarded on whether D3 six-cell embryos were good- or poor-quality embryos. Some studies regarded D3 six-cell embryos as good-quality embryos [4, 7], but few others showed them to be associated with low clinical pregnancy rates and increased abortion rates [2, 7].
Recent advancements in embryo culture media have led to a shift in ART practice from cleavage-stage embryo transfer to blastocyst-stage transfer [8]. Moreover, the transfer of blastocyst-stage embryos could improve the implantation rate, live birth rate, and other associated outcomes compared with embryo transfers in the cleavage stage [9]. However, information regarding the blastocyst rate and subsequent clinical outcomes in frozen embryo transfer cycles of D3 embryos with cell number ≤ 6 is scarce. This study mainly aimed to retrospectively analyze the clinical outcomes of the transfer of D3 embryos with cells ≤ 6 or blastocysts derived from extended culture of these embryos to determine whether D3 six-cell embryos had high developmental potential and whether the transfer of blastocysts by extended culture could substantially increase the chances for a successful pregnancy.
Materials and methods
Participants
The clinical data of patients undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycle for assisted pregnancy in the reproductive medicine center of Tangdu Hospital from January 2013 to December 2016 were retrospectively analyzed. Patients underwent controlled ovarian stimulation during natural or microstimulation cycles.
Methods
Controlled ovarian stimulation was performed according to the standard long and short antagonist protocols at the center. The dominant follicles achieved a diameter of ≥ 18 mm or at least three follicles had a diameter of ≥ 16 mm after administering 5000–10,000 U of human chorionic gonadotropin (HCG, Zhuhai, lizhu) or 250 μg Aize (Syrano, Switzerland) by intramuscular injection according to the estrogen levels. After 34–36 h, oocyte retrieval was performed with a transvaginal aspiration needle under the guidance of vaginal ultrasound.
Embryo culture and evaluation: IVF/ICSI technique was used for in vitro fertilization, and the fertilization results were evaluated 16–18 h after fertilization. Normal fertilized zygotes were cultured using a desktop three-gas incubator (COOK, K-MINC-1000) at 37 °C in the presence of 6% CO2, 5% O2, and 89% N2. According to the Istanbul embryo consensus, D3 embryo observation and evaluation were carried out after fertilization (68 ± 1 h) and blastocyst development was evaluated after fertilization (116 ± 2 h) [10]. This was followed by the selection of high-quality embryos for transfer. If no high-quality embryos were obtained, the embryos with more blastomeres, less fragments, and no obvious unevenness of blastomeres were selected.
Embryo evaluation criteria: D3 embryos in the cleavage stage were graded according to the standard of morphological grading in the laboratory: grade I: blastomere number in the embryos was > 6, blastomeres were even, and fragmentation was ≤ 5%; grade II: blastomere number in the embryos was > 6, blastomeres were slightly uneven, and fragmentation was ≤ 20%; grade III: blastomere number in the embryos ranged from 4 to 6, blastomeres were uneven, and fragmentation was between 20 and 50%; and grade IV: blastomere number in the embryos was < 4 and fragmentation was > 50%. The two-step scoring criteria proposed by Garden were adopted for grading blastocysts [11]: high-quality blastocysts were at stage 4 or higher of blastocyst expansion, with a scoring of 4BB or higher; and available blastocysts were at stage 3 or higher of blastocyst expansion, with a scoring of 3CC or higher.
Corpus luteum support and monitoring: After embryo transplantation, human chorionic gonadotropin (HCG) or progesterone was used to maintain the corpus luteum function, and blood HCG was detected on day 15. If HCG was positive, ultrasound examination was performed 4 weeks after the transfer and those with fetal heart beat were diagnosed with clinical pregnancy.
In this study, the D3 embryos were divided into groups with 4–5, 6, 7–9, and > 9 cells according to the number of blastomeres. First, the clinical pregnancy rate, implantation rate, and abortion rate were analyzed among groups in the fresh cycle. Second, the blastocyst formation rate, high-quality blastocyst rate, and available blastocyst rate were compared. Finally, the embryo implantation rate, clinical pregnancy rate, abortion rate, and other indicators of frozen–thawed cycle transfer of D3 embryos with different development rates after extending the culture to blastocysts were analyzed and compared.
Statistical analysis
SPSS16.0 statistical software was used for statistical analysis. The measurement data were expressed as mean ± standard deviation (\(\overline{x}\) ± s). Analysis of variance (ANOVA) was performed to compare between groups. A P value < 0.05 was considered to be statistically significant. The counting data were expressed as percentage (%). The comparison between groups was conducted using the chi-square test, and the difference was statistically significant if the P value was < 0.05.
Results
Comparison of general information
This study included 6331 IVF/ICSI cycles for assisted pregnancy. The clinical characteristics were compared. The results showed that age, infertility duration, Gn dosage, and days of ovulation induction of the patients were not significantly different (P ≥ 0.05) among the four groups. Moreover, no significant difference was found in the number of retrieved oocytes per cycle between the group with 4–5 cells (9.79 ± 5.31) and the other groups (P ≥ 0.05), while the number of retrieved oocytes was significantly higher in the group with 7–9 cells (10.71 ± 4.46) and > 9 cells (9.89 ± 5.22) than in the groups with 6 cells (8.11 ± 5.23) (P < 0.05; Table 1).
Pregnancy outcomes after fresh embryo transfer according to the number of blastomeres in the embryos on D3
The clinical pregnancy rates were 36.36, 27.85, 54.71, and 54.11 (%); the implantation rates were 21.21, 17.24, 38.06, and 37.50 (%); and the abortion rates were 8.33, 31.82, 13.86, and 12.00 (%), respectively, in the groups with 4–5, 6, 7–9, and > 9 cells after fresh embryo transfer on D3 (Table 2). The analysis of pregnancy outcomes of embryos in fresh transfer cycle in different groups showed no significant differences in the clinical pregnancy rate, implantation rate, and abortion rate between the groups with 4–5 and 6 cells (P ≥ 0.05). Meanwhile, no significant differences were observed in the clinical pregnancy rate, implantation rate, and abortion rate between the groups with 7–9 and > 9 cells (P ≥ 0.05). The clinical pregnancy rates were significantly lower in the groups with 4–5 and 6 cells than in the group with 7–9 cells (P < 0.05), while no significant difference was observed between the groups with 4–5 and > 9 cells (P ≥ 0.05). The clinical pregnancy rate significantly decreased in the group with 6 cells compared with the group with > 9 cells (P < 0.05). The implantation rate was significantly lower in the groups with 4–5 and 6 cells than in those with 7–9 and > 9 cells (P < 0.05). The abortion rate sharply increased in the group with 6 cells than in the groups with 4–5, 7–9, and > 9 cells (P < 0.05), while no significant difference in abortion rate was observed between the groups with 4–5, 7–9, and > 9 cells (P ≥ 0.05).
Developmental potential of embryos with different number of blastomeres
The blastocyst formation rate, high-quality blastocyst rate, and available blastocyst rate were compared among the groups with 4–5, 6, 7–9, and > 9 cells to explore the development potential of embryos with different blastomere numbers. The results revealed that the blastocyst formation rate increased with cell number by 28.17%, 41.73%, 53.83%, and 58.27% in embryos with 4–5, 6, 7–9, and > 9 cells, respectively (P < 0.01; Table 3). The good-quality blastocyst formation rate also increased with cell number by 9.77%, 12.59%, 29.85%, and 37.89% in embryos with 4–5, 6, 7–9, and > 9 cells, respectively (P < 0.01; Table 3). Meanwhile, the available blastocyst rate increased with cell number by 7.11%, 12.98%, 30.69%, and 36.35% (P < 0.01; Table 3) in the groups with 4–5, 6, 7–9, and > 9 cells, respectively. These results indicated that the developmental potential significantly increased with cell number on D3. In addition, the blastocyst formation rate of 6-cell embryos reached 41.73%, indicating that the 6-cell embryos have high developmental potential (Table 3).
Pregnancy outcomes of single blastocyst transfer after extended culture of embryos with different numbers of blastomeres
Next, the pregnancy outcomes of frozen–thawed cycle of embryos with different blastomere numbers after extended culture to blastocysts following single blastocyst transfer were analyzed. The clinical pregnancy rate and implantation rate were 61.36%, 62.79%, 66.80%, and 72.79% in the groups with 4–5, 6, 7–9, and > 9 cells, respectively (P ≥ 0.05; Table 4), with no significant difference. The abortion rate of blastocysts was significantly higher in the group with 4–5 cells than in that with 7–9 cells (P < 0.05; Table 4). However, the abortion rate of blastocysts in the group with 6 cells showed no significant differences compared with groups with 7–9 and > 9 cells (P ≥ 0.05; Table 4).
Pregnancy outcomes of double blastocyst transfer after extended culture of embryos with different blastomere number
The pregnancy outcomes of frozen–thawed cycle of embryos with different blastomere number after extended culture to blastocysts following double blastocyst transfer were also compared. The clinical pregnancy rate was 64.44%, 73.17%, 71.98%, and 81.61% in the groups with 4–5, 6, 7–9, and > 9 cells (Table 4). The pregnancy outcome of double blastocyst transfer in frozen–thawed cycles showed no significant differences in clinical pregnancy rate among the groups with 4–5, 6, and 7–9 cells (P ≥ 0.05; Table 4), whereas the clinical pregnancy rate significantly increased in the group with > 9 cells than in that with 4–5 cells (P < 0.05; Table 4). Furthermore, the implantation rate significantly increased in the groups with 7–9 and > 9 cells than in the group with 4–5 cells (39.78%, 52.91%, and 66.67%, respectively) (P < 0.05; Table 4). However, no significant differences were observed between the groups with 4–5 and 6 cells (39.78% vs 48.54; P ≥ 0.05). The implantation rate significantly increased in the group with > 9 cells than in that with 6 cells (P < 0.05; Table 4). No significant differences were found in the abortion rate among the groups with 4–5, 6, and 7–9 cells compared with the group with 4–5 cells. The abortion rate significantly decreased in the group with > 9 cells than in that with 4–5 cells (P < 0.05), but no significant differences were noted in the abortion rate between the groups with 6, 7–9, and > 9 cells (P ≥ 0.05; Table 5).
Discussion
The present study demonstrated that the fresh transfer of D3 embryos with 4–5 and 6 cells resulted in low clinical pregnancy and implantation rates and high abortion rate compared with that with D3 embryos with 7–9 and > 9 cells. In addition, no significant differences were observed in the clinical pregnancy rate and implantation rate between embryos with 4–5 and 6 cells. Also, the blastocyst formation rate in D3 6-cell embryos was 41.73%, which was lower than that obtained in embryos with 7–9 and > 9 cells, but higher than that in embryos with 4–5 cells. The transfer of single blastocysts from the extended culture of D3 embryos with 4–5 and 6 cells resulted in similar clinical pregnancy rate and implantation rate compared with embryos with 7–9 and > 9 cells. The transfer of double blastocysts from the extended culture of D3 developmentally retarded embryos also resulted in equivalent clinical pregnancy rates compared with embryos with 7–9 cells. These results suggested that the extended culture of D3 embryos with low blastomere number, particularly the 6-cell embryos, to blastocysts showed similar clinical pregnancy rates compared with blastocysts derived from D3 embryos with 7–9 and > 9 cells.
A low blastomere number of D3 embryos commonly indicated poor clinical outcomes [2, 6, 12]. The transfer of D3 four-cell embryos resulted in clinical pregnancies and live births, albeit a low rate [6]. According to time-lapse research, the implantation rate and live birth rate significantly decreased in D3 embryos with < 5 and 5–6 blastomeres compared with those with 7–10 blastomeres; the implantation rate and live birth rate of embryos with > 10 blastomeres were the highest [2]. However, Zhang et al. demonstrated that D3 embryos with < 6 blastomeres had decreased clinical pregnancy rates and increased abortion rates [4]. In addition, some studies indicated that D3 6-cell embryos were good-quality embryos with high developmental potential [4, 7]. In the present study, the transfer of D3 embryos with 4–5 and 6 cells resulted in a significant decrease in both implantation and clinical pregnancy rates and an increase in abortion rates compared with those with 7–9 and > 9 cells. However, these results demonstrated no significant differences in the clinical pregnancy rate, implantation rate, and abortion rate between embryos with 6 and 4–5 cells. The D3 embryos with 6 cells did not have high developmental potential compared with those with 4–5 cells, and might not be classified as good-quality embryos. The main reasons for poor clinical outcomes of D3 embryos with ≤ 6 blastomeres might be partly due to the embryo-endometrium asynchrony. The endometrium became receptive as a result of series of temporal and spatial hormonal events, contributing to the success of embryo implantation [13,14,15]. D3 embryos with 7–9 blastomeres demonstrated high implantation and pregnancy rates because their development was consistent with implantation window period. However, the embryonic development of D3 embryos with ≤ 6 blastomeres was delayed than the endometrium receptivity and missed the implantation window, resulting in a decline in implantation. This embryo-endometrium asynchrony could be overcome by thawing the frozen developmentally delayed cleavage-stage embryos on D3 for 24 h in advance and choosing to restore the mitotic embryos for transfer, thus increasing the implantation and pregnancy rates [16, 17].
Also, the blastocyst formation rate, high-quality blastocyst rate, and available blastocyst rate increased with blastomere number of D3 embryos. These results also indicated that the developmental potential of D3 embryos increased with the number of blastomeres. The blastocyst formation rate, high-quality blastocyst rate, and available blastocyst rate of D3 embryos with ≤ 6 blastomeres significantly decreased compared with embryos with more blastomeres. However, the blastocyst formation rate of D3 embryos with 6 cells was still considerable. Zhu et al. demonstrated that the blastocyst formation rate of D3 embryos with 6 cells reached 47.87% after extended culture, which was higher than that of embryos with 4–5 cells [7]. Kong et al. reported that the blastocyst formation rate of embryos with 5–6 cells was more than 40%, while the blastocyst formation rate of embryos with < 5 blastomeres was only 20.7% [2]. Similarly, Shapiro et al. showed that the blastocyst formation rate of D3 embryos with 6 and 5 blastomeres was 41.7% and 39%, respectively [18]. The results also confirmed that the blastocyst formation rate of D3 embryos with 6 cells was up to 41.73%, but it was only 28.17% for those with 4–5 cells. The blastocyst formation rate, high-quality blastocyst rate, and available blastocyst rate sharply decreased in embryos with 4–5 cells compared with those with 6 cells. The decreased developmental potential of D3 embryos with ≤ 6 blastomeres might be due to an increase in the chromosomal anomalies [19,20,21]. It was evident that D3 embryos with low blastomere numbers were at significantly elevated risk of aneuploidy [22]. Other studies based on trophectoderm biopsy and chromosomal analysis showed high aneuploidy rates in slow-developing blastocysts [23]. These studies demonstrated an association between chromosomal abnormality and embryo developmental rate. The results confirmed that D3 embryos with 6 cells showed a considerable blastocyst formation rate, indicating that the transfer of vitrified and warmed blastocysts developed from these D3 embryos might increase the chances of successful pregnancy.
Previous studies showed that the extended culture of D3 poor-quality embryos into blastocysts was then transferred into frozen–thawed cycle, resulting in good clinical pregnancy and implantation rates [24, 25]. After extended culture of embryos with poor developmental potential into blastocysts, the clinical pregnancy rate could reach 24.6% and the cumulative live birth rate increased from 43 to 47% [26]. The results showed no significant differences in the clinical pregnancy rate and implantation rate among the groups with 4–5, 6, 7–9, and > 9 cells in the single-blastocyst transfer cycle. However, the abortion rate of blastocysts derived from embryos with 4–5 cells was significantly higher than that derived from embryos with 7–9 cells. In the double-blastocyst transfer cycle, no significant differences were observed in the clinical pregnancy rate among the groups with 4–5, 6, and 7–9 cells. Although the implantation rate significantly decreased in blastocysts derived from the groups with 4–5 and 6 cells than in the group with 7–9 cells, equivalent clinical pregnancy outcomes occurred. These results demonstrated that blastocyst transfer derived from D3 embryos with ≤ 6 blastomeres resulted in similar clinical outcomes as embryos with > 6 blastomeres in either single- or double-blastocyst transfer cycles. Furthermore, the clinical pregnancy rate of single- and double-blastocyst transfer cycles of groups with 4–5 and 6 cells was > 60%, significantly higher than that of all four groups in fresh transfer cycles. These results indicated that extended culture provided an opportunity to screen high-quality embryos and eliminated the embryos with chromosomal abnormalities and/or poor developmental potential [21, 27]. Moreover, blastocyst transfer could avoid embryo-endometrium asynchrony, resulting in high clinical pregnancy rates compared with the fresh cycle [15, 28].
In conclusion, these results demonstrated that D3 embryos with ≤ 6 blastomeres were associated with low implantation and clinical pregnancy rates and high abortion rates compared with those with 7–9 and > 9 blastomeres. The extended culture of embryos with ≤ 6 blastomeres to blastocysts was then transferred to frozen–thawed cycle, resulting in good clinical pregnancy and implantation rates. These results indicated that the extended culture of D3 embryos with ≤ 6 blastomeres to blastocysts following frozen–thawed embryo transfer was an economical and effective method, improving the clinical pregnancy outcomes and relieving the economic burden and psychological pressure of patients [24, 26, 29]. The findings revealed that embryos with low blastomere number performed well in extended culture and frozen embryo transfer cycles.
However, this study still had some limitations. First, the data were retrospectively analyzed and the D3 fresh and extended culture warming cycles were not randomized. Second, the pre-implantation embryo stage is a vital period of epigenetic reprogramming, and the risk of abnormal imprinting may increase with the extension of in vitro operation and culture [30,31,32]. Whether extended culture interferes with embryonic imprinting and causes developmental defects still remains unclear. However, studies have shown that blastocyst stage transfer was associated with increased risks of preterm birth, very preterm birth, and large for gestational age [9, 33]. Finally, blastocyst-stage embryo transfer is associated with a risk of losing some embryos because these embryos may not survive in extended culture in vitro, but may survive in vivo if transferred on D3 [34]. Patients with fewer eggs have a high risk of no embryo transfer after extended culture. Therefore, it is not recommended to select extended culture for patients with few embryos, and embryo transfer should be carried out on D3 to improve the embryo utilization rate.
References
Desai NN, Goldstein J, Rowland DY, Goldfarb JM (2000) Morphological evaluation of human embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a preliminary study. Hum Reprod 15:2190–2196
Kong X, Yang S, Gong F, Lu C, Zhang S, Lu G, Lin G (2016) The relationship between cell number, division behavior and developmental potential of cleavage stage human embryos: a time-lapse study. PLoS ONE 11:e0153697
van Loendersloot L, van Wely M, van der Veen F, Bossuyt P, Repping S (2014) Selection of embryos for transfer in IVF: ranking embryos based on their implantation potential using morphological scoring. Reprod Biomed Online 29:222–230
Zhang S, Lu C, Lin G, Gong F, Lu G (2009) The number of blastomeres in post-thawing embryos affects the rates of pregnancy and delivery in freeze-embryo-transfer cycles. J Assist Reprod Genet 26:569–573
Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J (2000) Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod 15:2634–2643
Pereira N, Brauer AA, Melnick AP, Lekovich JP, Spandorfer SD (2015) Prognostic value of growth of 4-cell embryos on the day of transfer in fresh IVF-ET cycles. J Assist Reprod Genet 32:939–943
Zhu HB, Zhang ZH, Fadlalla E, Wang RX, Geng DF, Liu RZ (2014) Culturing surplus poor-quality embryos to blastocyst stage have positive predictive value of clinical pregnancy rate. Iran J Reprod Med 12:609–616
Glujovsky D, Farquhar C, Quinteiro Retamar AM, Alvarez Sedo CR, Blake D (2016) Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev 6:CD002118
Wang X, Du M, Guan Y, Wang B, Zhang J, Liu Z (2017) Comparative neonatal outcomes in singleton births from blastocyst transfers or cleavage-stage embryo transfers: a systematic review and meta-analysis. Reprod Biol Endocrinol 15:36
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26:1270–1283
Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB (2000) Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 73:1155–1158
Wu K, Zheng Y, Zhu Y, Li H, Yu G, Yan J, Chen ZJ (2014) Morphological good-quality embryo has higher nucleus spreading rate/signal resolution rate in fluorescence in situ hybridization. Arch Gynecol Obstet 290:185–190
Wong KM, Mastenbroek S, Repping S (2014) Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertil Steril 102:19–26
Paulson RJ, Sauer MV, Lobo RA (1990) Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol 163:2020–2023
Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S (2011) Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfers in high responders. Fertil Steril 96:516–518
Paria BC, Reese J, Das SK, Dey SK (2002) Deciphering the cross-talk of implantation: advances and challenges. Science 296:2185–2188
Burks H, Buckbinder J, Francis-Hernandez M, Chung K, Jabara S, Bendikson K, Paulson R (2015) Developmentally delayed cleavage-stage embryos maintain comparable implantation rates in frozen embryo transfers. J Assist Reprod Genet 32:1477–1481
Shapiro BS, Harris DC, Richter KS (2000) Predictive value of 72-hour blastomere cell number on blastocyst development and success of subsequent transfer based on the degree of blastocyst development. Fertil Steril 73:582–586
Daughtry BL, Chavez SL (2016) Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences. Cell Tissue Res 363:201–225
Kroener L, Ambartsumyan G, Briton-Jones C, Dumesic D, Surrey M, Munne S, Hill D (2012) The effect of timing of embryonic progression on chromosomal abnormality. Fertil Steril 98:876–880
Majumdar G, Majumdar A, Verma IC, Upadhyaya KC (2017) Relationship between morphology, euploidy and implantation potential of cleavage and blastocyst stage embryos. J Hum Rreprod Sci 10:49–57
Li G, He N, Jin H, Liu Y, Guo Y, Su Y, Sun Y (2015) The Influence of single nucleotide polymorphism microarray-based molecular karyotype on preimplantation embryonic development potential. PLoS ONE 10:e0138234
Alfarawati S, Fragouli E, Colls P, Stevens J, Gutierrez-Mateo C, Schoolcraft WB, Katz-Jaffe MG, Wells D (2011) The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril 95:520–524
Shaw-Jackson C, Bertrand E, Becker B, Colin J, Beaudoin-Chabot C, Rozenberg S, Autin C (2013) Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming. J Assist Reprod Genet 30:1035–1042
Zhao P, Li M, Lian Y, Zheng X, Liu P, Qiao J (2015) The clinical outcomes of day 3 4-cell embryos after extended in vitro culture. J Assist Reprod Genet 32:55–60
Kaartinen N, Das P, Kananen K, Huhtala H, Tinkanen H (2015) Can repeated IVF-ICSI-cycles be avoided by using blastocysts developing from poor-quality cleavage stage embryos? Reprod Biomed Online 30:241–247
Dekel-Naftali M, Aviram-Goldring A, Litmanovitch T, Shamash J, Yonath H, Hourvitz A, Yung Y, Brengauz M, Schiff E, Rienstein S (2013) Chromosomal integrity of human preimplantation embryos at different days post fertilization. J Assist Reprod Genet 30:633–648
Chandel NP, Bhat VV, Bhat BS, Chandel SS (2016) Outcome analysis of day-3 frozen embryo transfer v/s fresh embryo transfer in infertility: a prospective therapeutic study in Indian Scenario. J Obstet Gynaecol India 66:345–351
Sallem A, Santulli P, Barraud-Lange V, Le Foll N, Ferreux L, Maignien C, Bourdon M, Chapron C, de Ziegler D, Wolf JP, Pocate-Cheriet K (2018) Extended culture of poor-quality supernumerary embryos improves ART outcomes. J Assist Reprod Genet 35:311–319
Market-Velker BA, Fernandes AD, Mann MR (2010) Side-by-side comparison of five commercial media systems in a mouse model: suboptimal in vitro culture interferes with imprint maintenance. Biol Reprod 83:938–950
Natalie W, Siladitya B, Gwen H, Horgan GW, Mark H, Paul H (2014) Epigenetic status in the offspring of spontaneous and assisted conception. Hum Reprod 29:1452–1458
Pinborg A, Loft A, Romundstad LB, Wennerholm UB, Söderströmanttila V, Bergh C, Aittomäki K (2016) Epigenetics and assisted reproductive technologies. Acta Obstet Gynecol Scand 95:10–15
Martins WP, Nastri CO, Rienzi L, van der Poel SZ, Gracia CR, Racowsky C (2016) Obstetrical and perinatal outcomes following blastocyst transfer compared to cleavage transfer: a systematic review and meta-analysis. Hum Reprod 31:2561–2569
Levi-Setti PE, Cirillo F, Smeraldi A, Morenghi E, Mulazzani GEG, Albani E (2018) No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study. J Assist Reprod Genet 35:457–465
Acknowledgements
The authors thank the nurses and laboratory staff of the Department of Assisted Reproduction for their contribution to this study.
Funding
This study was supported by the grants from the Scientific and Technical Innovatory Project of Tangdu Hospital (2017LCYJ001, 2016LCYJ004 and 2019JSYJ003), the National Natural Science Foundation of China (31801250), and the Key Research and Development Program of Shaanxi, China (2018SF-258).
Author information
Authors and Affiliations
Contributions
BL, JLH: project development, data collection, manuscript writing. LL, XH: project development, data analysis. MW, HZH, YPH: data collection, manuscript writing. BK, YQSH: data collection, data analysis. SQCH, XHW: project development, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Ethical approval
The formal consent for this study was not required and was waived by the institutional review board. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, B., Huang, J., Li, L. et al. Improving the clinical outcomes by extended culture of day 3 embryos with low blastomere number to blastocyst stage following frozen–thawed embryo transfer. Arch Gynecol Obstet 303, 573–580 (2021). https://doi.org/10.1007/s00404-020-05774-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05774-1